SARS-CoV-2 3CLpro-IN-15

SARS-CoV-2 3CLpro-IN-15

• CAS Number: 3156-41-0
• UNSPSC Description: SARS-CoV-2 3CLpro-IN-15 (compound a) is a beta-nitrostyrene coronavirus SARS-CoV-2 inhibitor that targets the SARS-CoV-2 3CL protease (3CLpro). SARS-CoV-2 3CLpro-IN-15 inhibits viral replication and transcription and plays a key role in the discovery of anti-COVID-19 lead compounds[1].
• Target Antigen: SARS-CoV; Virus Protease
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-3clpro-in-15.html
• Solubility: 10 mM in DMSO
• Smiles: [O-][N+](/C=C/C1=CC=C([N+]([O-])=O)C=C1)=O
• Molecular Weight: 194.14
• References & Citations: [1]Jia ZJ, et al. Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease. J Mol Struct. 2023 Jul 15;1284:135409..
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported